Lipidor applies for bankruptcy

MAR

STOCKHOLM, Sweden, 25th May 2025 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the Company's board has resolved to file for bankruptcy on behalf of the Company. The bankruptcy application will be submitted today, 25th May 2025, to the Stockholm District Court.

The decision was made after Lipidor yesterday reported a negative result in the clinical Phase III study with the drug candidate AKP02G2, and the decision is based on a thorough review of various alternatives in light of the recently arisen financial situation that has occurred for the Company, due to the negative result of the clinical Phase III study and the resulting absence of planned capital contributions. After a comprehensive assessment, the board has concluded that the Company’s financing is insufficient to meet outstanding obligations and to continue operations.

In light of the above, the board of Lipidor has today, 25th May 2025, decided to apply for bankruptcy at the Stockholm District Court.

Datum 2025-05-25, kl 17:25
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!